Triple-negative breast cancer trials in Chile

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  Where

  Concepción, La Serena, Santiago, Viña del Mar

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06841354 · EU 2024-516834-36-00
• Phase 3Taking people
  A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  Where

  Santiago, Viña del Mar

  Age

  18 years and over

  People

  2,400 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06966700 · EU 2024-520190-12-00
• Phase 1/2Taking people
  A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  Where

  Santiago, Valdivia, Viña del Mar

  Age

  18 years and over

  People

  416 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06618287
• Phase 2/3Taking people
  A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  Where

  Santiago, Viña del Mar

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06926868 · EU 2024-519871-24-00